Unfortunately, his signature legislation coupled with the Food and Drug Administration's confusing and somewhat disjointed approval process has instead encouraged the off-shoring of business and brought medical discoveries to a halt.
Linking FDA processes and legislation to negative impacts on medical innovation.
Share & report
More from Michael Burgess
Mr. Speaker, I yield 5 minutes to the gentleman from Pennsylvania (Mr. Kelly), the sponsor of this resolution.
Mr. Speaker, I yield 2 minutes to the gentleman from Pennsylvania (Mr. Kelly), the sponsor of the resolution.
Madam Speaker, by direction of the Committee on Rules, I call up House Resolution 1486 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 1486 Resolved, That at any time after adoption of this…
Madam Speaker, I yield myself 3 minutes for the purposes of a response. First off, on Project 2025, this is the work of a think tank. Here is a news flash for everyone: There are think tanks in Washington, D.C. There are a lot of them…
Other voices in this conversation
